Though Novo Nordisk had a first-mover advantage in the GLP-1 market, Eli Lilly is catching up. Lilly's recent clinical progress sets it up for another critical approval. The company has fantastic ...
The Golden Agers from San Bernardino’s Akoma Unity Center are hosting their first Breast Cancer Walk, to support the Susan G. Komen organization, at 9 a.m. Saturday, Oct. 18, at Anne E. Shirrells Park ...
Missouri coach Eli Drinkwitz had plenty to say about his name surfacing in the college football coaching carousel -- and he didn't hold back. The Tigers sixth-year coach has been mentioned in recent ...
The “magazine girlies” of the late 1990s and early 2000s rom-coms carried an admirable aesthetic – frazzled-yet-chic journalists running around their skyscraper offices, chasing big city ambitions to ...
Page Six may receive compensation or an affiliate commission if you click on or make a purchase through our links. Prices are subject to change. We encourage supporting local and independent ...
Watch the video below as Missouri football reporter Joey Van Zummeren gives his thoughts on why Eli Drinkwitz leaving the program wouldn't make much sense for the head coach. Welcome to Missouri ...
Eli Drinkwitz wanted all of the blame for Missouri’s loss to Alabama football Saturday to be directed at him. “They got a good football team,” Drinkwitz said. “We just didn’t get it done today. Not ...
The Jaguars traded up to the No. 2 overall pick in this year’s draft to select two-way star Travis Hunter. The rookie has seen a decent amount of snaps on both sides of the ball this year, though he ...
Kristen Baldwin is a TV critic for Entertainment Weekly, and a writer and editor with 25 years of experience in entertainment journalism. Prior to EW, she served as editor-in-chief of Yahoo ...
This article originally appeared on PittsburghSPORTSNOW.com. A promising start from quarterback Eli Holstein and Pitt football turned sour Saturday afternoon as the Panthers’ second-year starter ...
Eli Lilly's trial met its primary endpoints in the treatment of type 2 diabetes. The secondary endpoints included weight loss, and, here again, orforglipron demonstrated superiority in the trial, ...